Brain

After 175 years, the medical art with a strange and dark history is getting a lot more precise.

We ask the experts what’s coming in the next 12 months.

Growing interest in psychedelic therapy reveals two different visions of the future: one of spiritual interconnectedness and one of sober neurochemistry.

The aspects that make them most creative may also be their biggest risk.

The fact that no two are alike could be the key to designing AIs that can adapt to change.

Major corporations are applying the lessons of cognitive neuroscience to get the American public buying.

Open-label placebos may defy logic, but scientists explore promising new treatment possibilities.

An emerging trend in interior design reframes the built environment as a way to help people flourish.

Hallucinations are a surprisingly common symptom of Parkinson’s, and new research suggests a way to map and potentially treat them.

Walter Greenleaf won’t stop until virtual reality and extended reality reach their full potential in health care.